Promising migraine combo drug study pulled before it began
NCT ID NCT05685225
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 26 times
Summary
This study aimed to test a new combination of naltrexone and acetaminophen for treating migraine headaches quickly. It was designed for adults with migraines and would have compared the combo to each drug alone and a placebo. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Keystone Clinical Research
North Miami, Florida, 33181, United States
Conditions
Explore the condition pages connected to this study.